These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 31910043)
21. Molecular Strategies for RPGR Gene Therapy. Cehajic Kapetanovic J; McClements ME; Martinez-Fernandez de la Camara C; MacLaren RE Genes (Basel); 2019 Sep; 10(9):. PubMed ID: 31487940 [TBL] [Abstract][Full Text] [Related]
22. Gene augmentation for X-linked retinitis pigmentosa caused by mutations in RPGR. Beltran WA; Cideciyan AV; Lewin AS; Hauswirth WW; Jacobson SG; Aguirre GD Cold Spring Harb Perspect Med; 2014 Oct; 5(2):a017392. PubMed ID: 25301933 [TBL] [Abstract][Full Text] [Related]
23. Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin. Ye GJ; Budzynski E; Sonnentag P; Miller PE; Sharma AK; Ver Hoeve JN; Howard K; Knop DR; Neuringer M; McGill T; Stoddard J; Chulay JD Hum Gene Ther Clin Dev; 2015 Sep; 26(3):165-76. PubMed ID: 26390090 [TBL] [Abstract][Full Text] [Related]
24. Phenotypic high myopia in X-linked retinitis pigmentosa secondary to a novel mutation in the RPGR gene. Sanchez Tocino H; Diez Montero C; Villanueva Gómez A; Lobo Valentin R; Montero-Moreno JA Ophthalmic Genet; 2019 Apr; 40(2):170-176. PubMed ID: 31033374 [TBL] [Abstract][Full Text] [Related]
25. Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR. Cehajic-Kapetanovic J; Xue K; Martinez-Fernandez de la Camara C; Nanda A; Davies A; Wood LJ; Salvetti AP; Fischer MD; Aylward JW; Barnard AR; Jolly JK; Luo E; Lujan BJ; Ong T; Girach A; Black GCM; Gregori NZ; Davis JL; Rosa PR; Lotery AJ; Lam BL; Stanga PE; MacLaren RE Nat Med; 2020 Mar; 26(3):354-359. PubMed ID: 32094925 [TBL] [Abstract][Full Text] [Related]
26. Advancing Gene Therapy for PDE6A Retinitis Pigmentosa. Petersen-Jones SM; Occelli LM; Biel M; Michalakis S Adv Exp Med Biol; 2019; 1185():103-107. PubMed ID: 31884596 [TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics of high myopia in female carriers of pathogenic Tran M; Kolesnikova M; Kim AH; Kowal T; Ning K; Mahajan VB; Tsang SH; Sun Y Ophthalmic Genet; 2023 Jun; 44(3):295-303. PubMed ID: 36017691 [TBL] [Abstract][Full Text] [Related]
28. Mapping of X-linked progressive retinal atrophy (XLPRA), the canine homolog of retinitis pigmentosa 3 (RP3). Zeiss CJ; Ray K; Acland GM; Aguirre GD Hum Mol Genet; 2000 Mar; 9(4):531-7. PubMed ID: 10699176 [TBL] [Abstract][Full Text] [Related]
29. Rd9 is a naturally occurring mouse model of a common form of retinitis pigmentosa caused by mutations in RPGR-ORF15. Thompson DA; Khan NW; Othman MI; Chang B; Jia L; Grahek G; Wu Z; Hiriyanna S; Nellissery J; Li T; Khanna H; Colosi P; Swaroop A; Heckenlively JR PLoS One; 2012; 7(5):e35865. PubMed ID: 22563472 [TBL] [Abstract][Full Text] [Related]
30. A frameshift mutation in RPGR exon ORF15 causes photoreceptor degeneration and inner retina remodeling in a model of X-linked retinitis pigmentosa. Beltran WA; Hammond P; Acland GM; Aguirre GD Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1669-81. PubMed ID: 16565408 [TBL] [Abstract][Full Text] [Related]
31. In Vivo CRISPR/Cas9-Mediated Genome Editing Mitigates Photoreceptor Degeneration in a Mouse Model of X-Linked Retinitis Pigmentosa. Hu S; Du J; Chen N; Jia R; Zhang J; Liu X; Yang L Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):31. PubMed ID: 32330228 [TBL] [Abstract][Full Text] [Related]
32. RPGR gene therapy presents challenges in cloning the coding sequence. Martinez-Fernandez De La Camara C; Cehajic-Kapetanovic J; MacLaren RE Expert Opin Biol Ther; 2020 Jan; 20(1):63-71. PubMed ID: 31612744 [No Abstract] [Full Text] [Related]
33. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene. Jacobson SG; Buraczynska M; Milam AH; Chen C; Järvaläinen M; Fujita R; Wu W; Huang Y; Cideciyan AV; Swaroop A Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1983-97. PubMed ID: 9331262 [TBL] [Abstract][Full Text] [Related]
34. RPGR-associated retinal degeneration in human X-linked RP and a murine model. Huang WC; Wright AF; Roman AJ; Cideciyan AV; Manson FD; Gewaily DY; Schwartz SB; Sadigh S; Limberis MP; Bell P; Wilson JM; Swaroop A; Jacobson SG Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5594-608. PubMed ID: 22807293 [TBL] [Abstract][Full Text] [Related]
35. Early Cone Photoreceptor Outer Segment Length Shortening in RPGR X-Linked Retinitis Pigmentosa. Menghini M; Jolly JK; Nanda A; Wood L; Cehajic-Kapetanovic J; MacLaren RE Ophthalmologica; 2021; 244(4):281-290. PubMed ID: 32209785 [TBL] [Abstract][Full Text] [Related]
36. Preclinical Dose-Escalation Study of Intravitreal AAV-RS1 Gene Therapy in a Mouse Model of X-linked Retinoschisis: Dose-Dependent Expression and Improved Retinal Structure and Function. Bush RA; Zeng Y; Colosi P; Kjellstrom S; Hiriyanna S; Vijayasarathy C; Santos M; Li J; Wu Z; Sieving PA Hum Gene Ther; 2016 May; 27(5):376-89. PubMed ID: 27036983 [TBL] [Abstract][Full Text] [Related]
37. Safety and Biodistribution Evaluation of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin, in RS1-Deficient Mice. Ye GJ; Conlon T; Erger K; Sonnentag P; Sharma AK; Howard K; Knop DR; Chulay JD Hum Gene Ther Clin Dev; 2015 Sep; 26(3):177-84. PubMed ID: 26390091 [TBL] [Abstract][Full Text] [Related]
38. Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia. Ye GJ; Budzynski E; Sonnentag P; Nork TM; Miller PE; McPherson L; Ver Hoeve JN; Smith LM; Arndt T; Mandapati S; Robinson PM; Calcedo R; Knop DR; Hauswirth WW; Chulay JD Hum Gene Ther Clin Dev; 2016 Mar; 27(1):27-36. PubMed ID: 27003752 [TBL] [Abstract][Full Text] [Related]
39. Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa. Pang JJ; Dai X; Boye SE; Barone I; Boye SL; Mao S; Everhart D; Dinculescu A; Liu L; Umino Y; Lei B; Chang B; Barlow R; Strettoi E; Hauswirth WW Mol Ther; 2011 Feb; 19(2):234-42. PubMed ID: 21139570 [TBL] [Abstract][Full Text] [Related]